The purpose of this study was to develop clinically-compatible methods for manufacturing photoreceptor precursor cells from adult skin in a non-profit cGMP environment. These studies will enable clinical trials to test the safety and efficiency of patient-specific photoreceptor cell replacement in humans. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965859/
cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness.
Fri, 07/29/2016 - 11:15